APRILE, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 588
EU - Europa 207
AS - Asia 111
AF - Africa 41
OC - Oceania 1
Totale 948
Nazione #
US - Stati Uniti d'America 578
IT - Italia 67
SG - Singapore 57
SE - Svezia 56
CN - Cina 41
CI - Costa d'Avorio 29
GB - Regno Unito 24
BG - Bulgaria 22
AT - Austria 18
CA - Canada 10
SN - Senegal 9
DE - Germania 8
VN - Vietnam 7
TR - Turchia 5
FI - Finlandia 4
FR - Francia 4
NG - Nigeria 3
CH - Svizzera 2
AU - Australia 1
RU - Federazione Russa 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 948
Città #
Fairfield 80
Woodbridge 67
Ann Arbor 48
Chandler 43
Ashburn 34
Houston 31
Wilmington 31
Abidjan 29
Cambridge 28
Seattle 28
Florence 26
Singapore 26
New York 24
Sofia 22
Santa Clara 19
Vienna 18
Boardman 17
Lawrence 13
Princeton 13
Dakar 9
Dearborn 9
Lancaster 9
London 9
Ottawa 9
Beijing 8
Medford 8
Bremen 7
Fuzhou 7
Des Moines 5
Istanbul 5
Shanghai 5
Lusciano 4
Milan 4
Seacroft 4
Kent 3
Lagos 3
Ogden 3
Quanzhou 3
Rome 3
San Diego 3
Washington 3
Carini 2
Changsha 2
Council Bluffs 2
Hebei 2
Hefei 2
Kunming 2
Los Angeles 2
Marseille 2
Nanjing 2
Shenyang 2
Turin 2
Bracknell 1
Capurso 1
Cento 1
Chengdu 1
Elk Grove Village 1
Frankfurt am Main 1
Geneve 1
Guangzhou 1
Indiana 1
Melbourne 1
Ninh Binh 1
Oakville 1
Phoenix 1
Piombino 1
Pisa 1
Pistoia 1
Redmond 1
Redwood City 1
Serra 1
Taizhou 1
Verona 1
Totale 763
Nome #
TRIBE-2: A phase III, randomized, open-label, strategy trial in unresectable metastatic colorectal cancer patients by the GONO group 145
Multicenter Prospective Study of Angiogenesis Polymorphism Validation in HCC Patients Treated with Sorafenib. An INNOVATE Study Protocol 99
A new nomogram for estimating survival in patients with brain metastases secondary to colorectal cancer 91
Single-agent panitumumab in frail elderly patients with advanced RAS and BRAF wild-type colorectal cancer: Challenging drug label to light up new hope 86
Ramucirumab for the treatment of gastric cancers, colorectal adenocarcinomas, and other gastrointestinal malignancies 84
Locally advanced gastro-oesophageal cancer: Recent therapeutic advances and research directions 71
null 68
Cholangiocarcinoma: new perspectives for new horizons 59
Homologous Recombination Deficiency Alterations in Colorectal Cancer: Clinical, Molecular, and Prognostic Implications 50
A prognostic model in patients with advanced biliary tract cancer receiving first-line chemotherapy 44
Impact of Baseline Characteristics on the Overall Survival of HCC Patients Treated with Sorafenib: Ten Years of Experience 43
Clinical insights and prognostic factors from an advanced biliary tract cancer case series: a real-world analysis 42
Clinico-pathological nomogram for predicting BRAF mutational status of metastatic colorectal cancer 28
Platinum sensitivity in patients with IDH1/2 mutated vs wild-type intrahepatic cholangiocarcinoma: A propensity score-based study 22
A perspective on the current management of advanced colorectal cancer 19
Validated clinico-pathologic nomogram in the prediction of HER2 status in gastro-oesophageal cancer 15
Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study 9
Totale 975
Categoria #
all - tutte 4.138
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.138


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020125 0 0 0 0 25 25 24 15 17 7 6 6
2020/202146 3 6 6 3 5 2 2 3 4 3 2 7
2021/2022122 0 2 6 2 15 31 2 5 11 10 9 29
2022/2023233 15 39 27 14 16 27 0 8 55 0 28 4
2023/2024128 5 11 23 4 14 21 11 4 4 2 10 19
2024/202596 4 24 23 28 17 0 0 0 0 0 0 0
Totale 975